China Resources Pharmaceutical Holdings Company Limited
发明人:
申请号：
EP18834742.1
公开号：
EP3656772A1
申请日:
2018.07.18
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Disclosed are a class of isoquinoline compounds acting as RHO protein kinase inhibitors, and the use thereof in the preparation of a drug for treating diseases associated with RHO protein kinase. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof.
